Ultrasonography Screening for Abdominal Aortic Aneurysms: A Systematic Evidence Review for the U.S. Preventive Services Task Force  by Guirguis-Blake, J.M. et al.
Abstracts
Gregory L. Moneta, MD, Section EditorUrgent Carotid Surgery and Stenting May Be Safe After Systemic
Thrombolysis for Stroke
Koraen-Smith L, Trëoeng T, Björck M, et al. Stroke 2014;45:776-80.
Conclusions: Urgent carotid endarterectomy or carotid artery stent-
ing after thrombolysis for stroke may be safe without an increased risk of
serious complications.
Summary: There is increasing evidence supporting the role of early
carotid endarterectomy (CEA) for severe carotid stenosis in the emergent
treatment of stroke. In addition, thrombolysis in hyperacute treatment of
cerebrovascular ischemia has also gradually increased. Increasing use of
thrombolysis to treat acute cerebral ischemia along with earlier surgery or
stenting for ischemic stroke makes it likely that the number of patients
who have received thrombolytic therapy and are considered for carotid
bifurcation intervention, will increase. There is, however, little known about
the results and safety of early CEA or carotid artery stenting (CAS) after
thrombolytic therapy for acute cerebral ischemia. In this study the authors
conducted a review of prospectively collected data in the Swedish National
Registry for Vascular Surgery (Swedvasc) and the Swedish Stroke Registry
(Riks-Stroke) from May 1, 2008 to December 11, 2012. The goal was to
investigate the safety of urgently performed CEA or CAS in patients treated
with thrombolysis for stroke. There were 3998 patients who underwent
CEA or CAS for symptomatic carotid stenosis between May 2008 and
December 2012. 79 of these patients (2%) had undergone previous throm-
bolysis for stroke. Retrospective review of this data and individual case re-
cords with regard to postoperative complications was performed.
Variables analyzed included surgical-site bleeding, stroke, and death. Out-
comes were compared to results of the patient cohort of 3919 patients un-
dergoing carotid surgery or stenting during the study period without pre-
procedure thrombolysis. Median time between thrombolysis and the carotid
bifurcation procedure was 10 days. There were 71 patients who underwent
carotid endarterectomy and 6 patients who underwent carotid artery stent-
ing after thrombolysis for acute stroke. 30-day death and stroke rate for the
thrombolysis cohort was 2.5% (2 or 79) and for the entire cohort it was 3.8%
(139 of 3626; P ¼ .55). Postoperative bleeding rates were not signiﬁcantly
different between the groups (3.8% in the thrombolysis group vs 3.3% in the
whole cohort; P ¼ .79). There was no correlation between time from lysis to
surgery or stenting and complications at 30 days postoperatively.
Comment: In this series, urgent procedures for high-grade carotid ar-
tery stenosis did not appear to carry an increased risk of complications after
thrombolysis for stroke. However, the median time between thrombolysis
and the carotid procedure was 10 days and it is possible that earlier surgery
could have an increased rate of complications. The timing of surgery
following thrombolytic therapy for acute stroke must be balanced against
the risk of further cerebral ischemic events. This study is by no means deﬁn-
itive as it is small and retrospective in design. It is based on a registry data
collection with all those inherent limitations. However, there is nothing
here to indicate that an urgent carotid procedure at least at a median of
10 days following thrombolysis for acute stroke is of increased risk
compared to CEA or CAS for symptomatic carotid stenosis without preced-
ing thrombolysis.
Open Aortic Repair After Prior Thoracic Endovascular Aortic Repair
Roselli EE, Abdel-Halim M, Johnston DR, et al. Ann Thorac Surg
2014;97:750-7.
Conclusions: There are a variety of indications for conversion to open
repair after thoracic endovascular stent grafting. The operations are compli-
cated and the long term results are consistent with the chronic disease state
of the patients.
Summary: Since the induction of thoracic endovascular stent grafting
the technique has inevitably been applied to increasingly complex aortic pa-
thology. In fact, it is now estimated that nearly two-thirds of thoracic aortic
stent grafts are deployed outside the instructions for use, or “off-label”.
Inevitably it is to be expected that the use of this technique for increasingly
complex aortic pathology is going to result in some late complications.
Some of these late complications will require conversion to open repair.
The objectives of this study were to: (1) characterize patients undergoing
open thoracic areas repair after prior TEVAR, (2) assess the indications
for conversion and operative techniques used, and (3) assess late and early
outcomes. The authors performed a chart review of their prospectively264collected database of patients undergoing thoracic endovascular arterial
repair. They identiﬁed 50 patients who underwent a follow-up open aortic
operation after prior TEVAR. The patients were also analyzed with the So-
cial Security information for vital status. From July 2001 to January 2012
open arch (n ¼ 25), descending (n ¼ 6), thoracoabdominal (n ¼ 17),
or extra-anatomic bypass (n ¼ 2) operations were performed after previous
TEVAR. Median time from TEVAR to the open surgical procedure was
13.9 months with an interquartile range of 0.5 to 24 months. Indications
for open operation included type endoleaks (n ¼ 19), retrograde aortic
dissection (n ¼ 9), chronic aortic dissection with persistent false lumen
growth (n ¼ 16), and graft infection (n ¼ 6). 60% of the patients had prior
cardiovascular surgical procedures and 18% were done as emergencies.
Circulatory support was required in 78% of the patients and hypothermic
arrest techniques were used in 48%. Hospital mortality was 6% with no
strokes and 1 myocardial infarction. 10% of patients (n ¼ 5) required trache-
ostomy and 1 required dialysis. Survival was 67% at a median follow-up
of 2.9 years.
Comment: New procedures bring with them new complications.
New complications will require innovative approaches. In this series the
types of operations could be broadly classiﬁed as conversions to conven-
tional repair and so-called reverse frozen elephant trunk, hybrid debranch-
ing procedures and extra-atomic bypass with subsequent stent graft
removal and aortic oversew. Despite the author’s excellent results with these
highly complicated operations in difﬁcult patients, with only 6% periopera-
tive mortality, and no strokes or paraplegia, results are not likely generaliz-
able to centers with less experience in the management of difﬁcult thoracic
aortic patients. Interestingly enough, like with open operations in the pres-
ence of abdominal aortic endografts, the stent graft itself can many times be
preserved, at least partially, in these procedures. When sewing to the stent
graft itself the authors advise including the adventitial layer of the aorta in
the anastomosis, such that the previous stent graft is somewhat analogous
to a new intimal layer.
Ultrasonography Screening for Abdominal Aortic Aneurysms: A
Systematic Evidence Review for the U.S. Preventive Services Task
Force
Guirguis-Blake JM, Beil TL, Senger CA, et al. Ann Intern Med
2014;160:321-9.
Conclusions: A one-time invitation for abdominal aortic aneurysm
(AAA) screening in men aged 65 years or older is associated with decreased
AAA rupture and AAA-related mortality rates but has little or no effect on
all-cause mortality.
Summary: Long-term follow-up and population-based randomized,
controlled trials, have demonstrated that screening for AAAs $3 cm in
diameter, decreases AAA related mortality rates in men aged 65 years or
older. The U.S. Preventative Services Task Force (USPSTF) evaluates
screening modalities for various diseases with respect to both beneﬁts and
harms. In 2005, the USPSTF found evidence to recommend 1-time
screening for AAA by ultrasonography in men aged 65 to 75 years who
had ever smoked. At that time, the USPSTF concluded beneﬁts sustained
did not clearly outweigh the harms and did not make a general recommen-
dation for or against screening for AAA in men aged 65 to 75 years who had
never smoked. They also recommended against routine screening for AAA
in women (U.S. Preventative Services Task Force, Ann Intern Med 2005;
42:198-202). In the current paper the USPSTF have included newly iden-
tiﬁed literature and all trials from the previous review that met current inclu-
sion criteria in an effort to provide updated evidence on the effectiveness of
1-time and repeated ultrasound screening for AAAs. Data sources included
MEDLINE, the Database of Abstracts of Reviews of Effects, the Cochrane
Central Register of Controlled Trials (Jan 2004-Jan 2013), clinical trial reg-
istries, references, experts, and a targeted search for population-based
screening randomized clinical trials through September 2013. Studies
were selected if they were in the English language, were population-based,
of fair to good quality and randomized. Large cohort studies for AAA
screening beneﬁts as well as randomized clinical trials and cohort or registry
studies for harms in adults with AAA were also included. Overall review of
four RCTs involving 137,214 participants demonstrated that a 1-time invi-
tation for AAA screening in men aged 65 years or older reduced AAA
rupture and AAA-related mortality rates for 10 to 15 years, respectively.
There was, however, no statistically signiﬁcant effect of all-cause mortality
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elective surgeries and fewer emergency operations and lower 30-day opera-
tive mortality rates at up to 10- to 15-years of follow-up. One RCT
involving 9342 women showed that screening had no beneﬁt on AAA
related mortality or all-cause mortality rates in women.
Comment: This updated review by the USPSTF reconﬁrms the value
of aneurysm screening in older males. The data remains limited by the fact
that the trials included for this evaluation consists mostly of white men
outside the United States and there’s little information about subgroups
and rescreening. Screening for abdominal aortic aneurysm thus far remains
the only vascular condition in which the USPSTF has found beneﬁt for the
screening process, with this group previously coming out against screening
for peripheral arterial disease and screening for carotid artery stenosis.
Optimizing the Outcome of Vascular Intervention for Takayasu’s
Arteritis
Perera AH, Youngstein T, Gibbs RGJ, et al. Br J Surg 2014;101:43-50.
Conclusions: Perioperative assessment in a detailed fashion will
improve vascular outcomes of Takayasu’s arteritis with focus on measure-
ment of disease activity and using optimal immunomodulatory therapy
before and after the procedure.
Summary: Takayasu’s arteritis (TA) is a large-vessel vascular arteritis
characterized by granulomatous changes of the aorta and its major branches.
The typical patient is under 40 years of age and the Takayasu’s process results
in stenotic or occlusive lesions predisposed to symptoms of end-organ
ischaemia such as claudication or hypertension. Less commonly there is
medial degeneration and aneurysmal dilation. There are numerous imaging
modalities including [18 F] ﬂuorodeoxyglucose combined positron emission
and computed tomography (18F-FDG-PET-CT), Doppler ultrasonography,
magnetic resonance angiography or CT angiography that have the ability to
identify prestenotic disease, and to reveal the extent of arterial injury and
perhaps to help monitor the response to immunomodulatory therapy (Ma-
son JC, Nat Rev Rheumatol 2010;6:406-415). Poor outcomes in patients
with Takayasu’s arteritis have been attributed to delayed diagnosis, which
may result from a lack of awareness of the condition, as well as late adminis-
tration of adequate medical treatment. Poor outcomes also can result from
inadequate patient selection and suboptimal timing of vascular intervention.
The authors sought to analyze, retrospectively, a cohort of patients with
Takayasu’s arteritis in the UK, to try to identify and analyze outcomes of
open surgical and endovascular interventions and to report concurrent use
of imaging before and after the procedure and also to investigate the impact
of perioperative immunosuppressive therapy. This was a retrospective view of
patients with Takayasu’s arteritis referred from 2001 and 2012 to a single ter-
tiary care center. 97 patients with Takayasu’s arteritis were seen. Immuno-
suppression was required in 87 patients (90%). Thirty-seven (38%)
underwent 64 procedures: 27 patients underwent 33 open surgical proce-
dures and 20 patients had 31 endovascular procedure. After a median
follow-up of 6 years, the overall success rate was 79% for open surgery
(mean graft patency, 9.4 years) and 52% for endovascular procedures (P ¼
.035). Procedural failure was reduced in patients receiving perioperative
immunosuppression, particularly in those with endovascular procedures (P
¼ .001). Clinical examination, measurement of acute-phase reactants and
combination non-invasive imaging including Doppler ultrasonography,
[18F] ﬂuorodeoxyglucose combined positron emission and computed to-
mography (CT), magnetic resonance angiography and CT angiography
were used to identify arterial lesions, establish the diagnosis and monitor
treatment outcomes. Overall and cumulative intervention failure rate was
34% (22 of 64), 7 (21%) of the 33 open and 15 (48%) of the 31 endovascular
procedures. Analyses of the outcomes of intervention suggested signiﬁcantly
improved results in those who received immunosuppression before an endo-
vascular intervention (P ¼ .001), but not necessarily for those that received
an open surgery (P ¼ .095). Six of the seven failed open procedures were
done in patients who did not receive preoperative medical therapy. 14 of
15 open procedures in patients who received medical therapy achieved
long-term patency (93%). In the endovascular group, 13 or the 15 failed pro-
cedures were not associated with preoperative immunomodulatory therapy.
However, 12 of 14 endovascular procedures associated with preoperative
immunomodulatory therapy remained patent.
Comment: In general, immunosuppression at the time of surgery is
considered a potential cause of postoperative complications. In this series,
however, no patient receiving immunosuppressive therapy at the time of
their procedure had a life-threatening complication and there were no dele-
terious effects of immunosuppressive therapy on surgical recovery or wound
infection noted. The data here would suggest that active suppression of the
Takayasu disease process at the time of therapy with immunosuppression
should be strongly considered with the beneﬁts of improved reconstruction
patency outweighing the adverse effects of the immunosuppression in the
perioperative period.Introduction of Surgical Safety Checklists in Ontario, Canada
Urbach DR, Govindarajan A, Saskin R, et al. N Engl J Med
2014;370:1029-38.
Conclusions: Implementation of surgical safety checklists in Ontario,
Canada did not result in signiﬁcant reductions of operative mortality or
complications.
Summary: In 2009, a study was published that suggested the imple-
mentation of a 19-item World Health Organization (WHO) Surgical Safety
Checklist substantially reduces the rate of surgical complications, from
11.0% to 7.0% in that study, and reduced the rate of in-hospital deaths
from 1.5% to 0.8% (Haynes AB et al, N Engl J Med 2009;360:491-9).
Largely as a direct result of that study surgical safety checklists were imple-
mented in thousands of hospitals world-wide in an effort to reduce in-hos-
pital complications and mortality. However, studies of the effects of
implementations of these checklists have been observational and limited
to small numbers of centers, and frequently have not evaluated patient out-
comes and have not showed the magnitude of effectiveness found in the
WHO study. Only studies including team training, and more comprehen-
sive safety systems that included multiple checklists have shown effectiveness
similar to those seen in the WHO study (Young-Xu Y et al, Arch Surg
2011;146:1368-73, and de Vries EN et al, N Engl J Med
2010;363:1928-37). In Ontario, Canada the Ministry of Health and
Long-Term Care mandated public reporting of adherence to surgical safety
checklists for hospitals beginning in July 2010. The authors felt this rapid
implementation of surgical safety checklists in Ontario was a natural exper-
iment to evaluate the effectiveness of checklist implementation at the pop-
ulation level in typical practice settings. They surveyed all acute care
hospitals in Ontario to determine when surgical safety checklists were adop-
ted. Using administrative health data they then compared operative mortal-
ity and rates of surgical complications linked to hospital stay and rates of
hospital readmission and urgent or emergency department visits within
30 days after discharge among patients undergoing a variety of surgical pro-
cedures, before and after adoption of the checklists. During the 3-month
period before and after adoption of the surgical safety checklists a total of
101 hospitals performed 109,341 and 106,370 procedures, respectively.
Adjusted risk of death during a hospital stay within 30 days after surgery
was 0.71% (95% CI, 0.66-0.76) before implementation of a surgical check-
list and 0.65% (95% CI, 0.60-0.70) afterward (odds ratio, 0.91; 95% CI,
0.80-1.03; P ¼ .13). Adjusted risk of surgical complications was 3.86%
(95% CI, 3.76-3.96) before implementation and 3.82% (95% CI, 3.71-
3.92) afterward (odds ratio, 0.97; 95% CI, 0.90-1.03; P ¼ .29).
Comment: The absence of effect of checklist implementation in this
study may reﬂect many possibilities. Perhaps published evidence on the ef-
ﬁcacy of implementing checklists within hospitals that participate in safety
research is not generalizable to all hospitals. Surgical safety checklists may
also be less effective in practice than suggested by existing literature.
Perhaps, as the authors point out, there is a Hawthorne Effect with a ten-
dency to perform better when work is under scrutiny that may explain the
strong effect of surgical safety checklists in studies in which hospitals where
workers were aware of the intervention under study. There may also be pub-
lication bias in that hospital based studies showing improvements in out-
comes after checklist implementation are more likely to be published than
negative studies. Also, as noted above, there may also be a greater effect
of surgical safety checklists when intensive team training is utilized along
with implementation of the checklists, and where there is better monitoring
compliance. Nevertheless, it does appear that the effectiveness of surgical
safety checklists, which have never been evaluated in a randomized control
trial, perhaps should undergo greater scrutiny.
Mortality From Ruptured Abdominal Aortic Aneurysms: Clinical
Lessons From a Comparison of Outcomes in England and the USA
Karthikesalingam A, Holt PJ, Vidal-Diez A, et al. Lancet 2014;383:963-9.
Conclusions: In-hospital survival from ruptured abdominal aortic
aneurysm (rAAA), intervention rates, and use of endovascular repair are
lower in England than in the USA. In England and the USA, lowest mor-
tality for rAAA is seen in teaching hospitals with larger bed capacities and
doing a greater proportion of cases with endovascular repair.
Summary: Outcomes of patients with rAAA vary by country. There
are likely modiﬁable technical, organizational and hospital related factors
that play important roles in patient care and outcomes of rAAA. Such vari-
ables merit further study to help optimize service delivery and improve pa-
tient outcomes for care of what is otherwise a fatal disease. In this paper, the
authors compare data from the Hospital Episode Statistics for England and
the Nationwide Inpatient Sample for the USA for patients admitted to hos-
pital with rAAA from 2005 to 2010. Primary outcomes were in-hospital
mortality, mortality after intervention, and decision to follow noncorrective
treatment. In-hospital mortality and the rates of non-corrective treatment
